Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Gynecology

Free Subscription 16.03.2026 5 Acta Obstet Gynecol Scand 6 Am J Obstet Gynecol 2 Am J Surg Pathol 2 Anticancer Res 1 Aust N Z J Obstet Gynaecol 5 BMC Cancer 1 BMJ 2 Br J Cancer 1 Cancer 2 Cancer Lett 1 Clin Cancer Res 1 Eur J Cancer 9 Eur J Obstet Gynecol Reprod Biol 2 Fertil Steril 19 Gynecol Oncol 3 Hum Pathol 3 Hum Reprod 5 Int J Cancer 12 Int J Gynaecol Obstet 1 Int J Oncol 3 J Clin Endocrinol Metab 1 JAMA 1 Lancet 2 Obstet Gynecol 1 Oncogene 1 PLoS Med 5 PLoS One 1 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. SALMERI N, Piccini M, Caprara F, Somigliana E, et al
   Impact of combined oral contraceptives and progestin-only pills on psychological and sexual well-being of women with endometriosis: A systematic review.
   Acta Obstet Gynecol Scand. 2026 Mar 12. doi: 10.1111/aogs.70183.
   PubMed         Abstract available
   
   
2. LUGOWSKI F, Wlodarczyk Z, Owczarek A, Zaborowska L, et al
   Port-site hernia following laparoscopic gynecological surgery: A systematic review and meta-analysis.
   Acta Obstet Gynecol Scand. 2026 Mar 10. doi: 10.1111/aogs.70176.
   PubMed         Abstract available
   
   
3. SHABANA H, Rodriguez-Wallberg KA
   The microbiome research in obstetrics and gynecology is getting attention-Some reasons why.
   Acta Obstet Gynecol Scand. 2026 Mar 7. doi: 10.1111/aogs.70184.
   PubMed        
   
   
4. COELINGH BENNINK HJT, Afors K, Bahamondes L, Graziottin A, et al
   A concept for a new approach to combined oral contraception from adolescence to perimenopause: Continuous use of the oral GnRH antagonist Relugolix and the fetal estrogen Estetrol.
   Acta Obstet Gynecol Scand. 2026 Mar 7. doi: 10.1111/aogs.70182.
   PubMed         Abstract available
   
   
5. DOWTHWAITE S, Quinton A, Thomas S, Schlub TE, et al
   Outcomes from blind versus ultrasound-guided uterine evacuation: A retrospective cohort analysis.
   Acta Obstet Gynecol Scand. 2026 Mar 6. doi: 10.1111/aogs.70179.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

6. YAZDY GM, Workowski KA, Ghanem KG, Burke AE, et al
   Male partner treatment and the potential sexual transmission of bacterial vaginosis: considerations for patient counseling and clinical application in the United States.
   Am J Obstet Gynecol. 2026;234:606-612.
   PubMed         Abstract available
   
   
7. MATEUS NINO J, Combs CA, Davidson C
   Society for Maternal-Fetal Medicine Special Statement: Checklists for transabdominal cerclage.
   Am J Obstet Gynecol. 2023;229:B2-B6.
   PubMed         Abstract available
   
   
8. SORRENTI S, Deuster E, D'Antonio F, Mascio DDI, et al
   Parvovirus B19 Infection in Pregnancy: Perinatal Outcomes Derived from a Systematic Review and Meta-Analysis.
   Am J Obstet Gynecol. 2026 Mar 10:S0002-9378(26)00133.
   PubMed         Abstract available
   
   
9. YUAN X, Pan K, He Y
   Reframing modifiable risk factors driving racial disparities in postoperative outcomes following benign hysterectomy (Letter-to-the-Editor).
   Am J Obstet Gynecol. 2026 Mar 4:S0002-9378(26)00127.
   PubMed        
   
   
10. WALLIS B, Carter G, Gimbel LA, Wright E, et al
    Associations Between Self-Reported Mood-Related Symptoms and Early Contraceptive Method Discontinuation.
    Am J Obstet Gynecol. 2026 Mar 4:S0002-9378(26)00130.
    PubMed         Abstract available
    
    
11. RASKIN L, Didembourg M, Dogne JM, Locquet M, et al
    Venous Thromboembolism with Combined Oral Contraceptives Based on Estrogen and Progestin Content: A disproportionality analysis of the United States Food and Drug Administration Adverse Event Reporting System database.
    Am J Obstet Gynecol. 2026 Mar 4:S0002-9378(26)00129.
    PubMed         Abstract available
    
    

    
    Am J Surg Pathol

12. DEVINS KM, Lin LH, Fisch AS, Dias-Santagata D, et al
    DICER1-Related Primitive Polyphenotypic Neoplasm: A Report of 15 Cases of an Underrecognized Tumor of the Gynecologic Tract and Peritoneum.
    Am J Surg Pathol. 2026 Mar 9. doi: 10.1097/PAS.0000000000002517.
    PubMed         Abstract available
    
    
13. LENGYEL K, Musick A, Fisch AS, Lin LH, et al
    Adnexal Endometrioid Carcinomas With Sex Cord-Like Morphology are Frequently PAX8-Negative, SOX17-Positive, and Enriched for CTNNB1 Alterations.
    Am J Surg Pathol. 2026 Mar 11. doi: 10.1097/PAS.0000000000002537.
    PubMed         Abstract available
    
    

    
    Anticancer Res

14. LIAKOU C, Pandraklakis A, LA Russa MC, Turnbull H, et al
    Interval Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Ovarian Cancer: Report of a Single-center Experience.
    Anticancer Res. 2023;43:4593-4599.
    PubMed         Abstract available
    
    
15. SAILLANT A, Rasclard M, Gaume JB, Souchaud O, et al
    A Case of Anti-3-hydroxy-3-methylglutaryl-coenzyme A Reductase Myopathy Associated With Advanced Cervical Carcinoma.
    Anticancer Res. 2023;43:4723-4727.
    PubMed         Abstract available
    
    

    
    Aust N Z J Obstet Gynaecol

16. SAMOYLOVICH A, Jennings B, Shannon C, Coward JI, et al
    Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context.
    Aust N Z J Obstet Gynaecol. 2023;63:702-708.
    PubMed         Abstract available
    
    

    
    BMC Cancer

17. ABERA GB, Alemayehu M, Sori DA, Ali R, et al
    Time to death and its determinants among cervical cancer patients in Tigray, Ethiopia: a retrospective follow up study.
    BMC Cancer. 2026 Mar 2. doi: 10.1186/s12885-026-15712.
    PubMed         Abstract available
    
    
18. CHEN X, Li J, Sun Y, Ye Z, et al
    LncRNA EGFR-AS1 inhibits ferroptosis to reduce radiosensitivity of cervical cancer through the m6A/IGF2BP3/APAF1 axis.
    BMC Cancer. 2026 Mar 5. doi: 10.1186/s12885-026-15596.
    PubMed        
    
    
19. WU M, Jiang Z, Xian X, Lu M, et al
    Transrectal ultrasound-guided optimization of needle insertion for interstitial brachytherapy in the treatment of vaginal stump recurrence of cervical cancer.
    BMC Cancer. 2026 Mar 7. doi: 10.1186/s12885-026-15819.
    PubMed        
    
    
20. OUMA GE, Asaso Omwodo K, Itsura P, Poli PA, et al
    Characterizing trimodal therapy outcomes by HIV status in early-stage cervical cancer: a retrospective cohort study from a Kenyan tertiary center.
    BMC Cancer. 2026 Mar 9. doi: 10.1186/s12885-026-15761.
    PubMed        
    
    
21. CUI YM, Shan YM, Xiao YY, Gao Y, et al
    Analysis of prognosis in early-stage cervical cancer patients post-conization treated with laparoscopic versus open radical hysterectomy.
    BMC Cancer. 2026 Mar 10. doi: 10.1186/s12885-026-15756.
    PubMed        
    
    

    
    BMJ

22. WISE J
    Menopause: NICE approves daily pill for hot flushes.
    BMJ. 2026;392:s477.
    PubMed        
    
    

    
    Br J Cancer

23. CHOI JA, Kim H, Kwon H, Lee EH, et al
    Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer.
    Br J Cancer. 2023 Aug 18. doi: 10.1038/s41416-023-02355.
    PubMed         Abstract available
    
    
24. MITCHELL AR, Chen Y, Pugliese G, Vino Flores G, et al
    Investigating PAK inhibition in combination with PD-1 blockade to enhance cytotoxic CD8+ T cell-mediated killing and suppress invasion of ovarian cancer cells.
    Br J Cancer. 2026 Mar 6. doi: 10.1038/s41416-026-03342.
    PubMed         Abstract available
    
    

    
    Cancer

25. HAN K
    Advancing molecular residual disease detection in cervical cancer through next-generation sequencing of circulating human papillomavirus DNA.
    Cancer. 2026;132:e70352.
    PubMed        
    
    

    
    Cancer Lett

26. YOU J, Liu J, Bao Y, Wang L, et al
    Corrigendum to Cancer Lett. 385 (2017) 271-279.
    Cancer Lett. 2026 Mar 9:218274. doi: 10.1016/j.canlet.2026.218274.
    PubMed        
    
    
27. YUE S, Wang Q, Zhang J, Hu Q, et al
    Understanding cervical cancer at single-cell resolution.
    Cancer Lett. 2023 Sep 26:216408. doi: 10.1016/j.canlet.2023.216408.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

28. GRISHAM RN, Vergote I, Banerjee S, Drill E, et al
    Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer.
    Clin Cancer Res. 2023 Aug 15:CCR-23-0621. doi: 10.1158/1078-0432.CCR-23-0621.
    PubMed         Abstract available
    
    

    
    Eur J Cancer

29. SCHWAMEIS R, Fanfani F, Ebner C, Zimmermann N, et al
    Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres.
    Eur J Cancer. 2023;193:113317.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

30. DELLA CORTE L, Palumbo M, Mignogna C, Varricchio S, et al
    Immunohistochemical and serum profile of squamous cell carcinoma of the vulva: The Dual Vulvar Panel (DVP) project.
    Eur J Obstet Gynecol Reprod Biol. 2026;320:115006.
    PubMed         Abstract available
    
    
31. VAN DEN BOSCH OFC, Tabernee-Heijtmeijer ESE, Damhuis SE, Ganzevoort W, et al
    Letter to the Editor: Diverging findings on epidural labor analgesia in small-for-gestational-age and fetal growth restricted pregnancies: lessons learned on maternal and fetal safety.
    Eur J Obstet Gynecol Reprod Biol. 2026;321:115067.
    PubMed        
    
    
32. CHENG X, Ouyang Y, Wang P, Zhang S, et al
    Induction of labor versus standard care for suspected large-for-gestational-age fetuses: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2026;321:115033.
    PubMed         Abstract available
    
    
33. BULLE C, Ramanah R, Caroff A, Berdin A, et al
    Association between patient knowledge and quality of life in endometriosis: A cross-sectional study.
    Eur J Obstet Gynecol Reprod Biol. 2026;321:115043.
    PubMed         Abstract available
    
    
34. LI S, Wang Y, Huang R, Yang L, et al
    Sequential three-dimensional ultrasound diagnosis of a T-shaped uterus.
    Eur J Obstet Gynecol Reprod Biol. 2026;321:115052.
    PubMed         Abstract available
    
    
35. ALIJOTAS-REIG J, Esteve-Valverde E, Saez-Comet L, Anunciacion-Llunell A, et al
    Impact of the 2023 ACR/EULAR antiphospholipid syndrome criteria in 1200 women with prior obstetric antiphospholipid syndrome.
    Eur J Obstet Gynecol Reprod Biol. 2026;321:115055.
    PubMed         Abstract available
    
    
36. BERNADETTE L, Miriam T, Islam A, Ruwan F, et al
    The relationship between uterine and fibroid volume with urinary symptoms as reported in the King's Health Questionnaire.
    Eur J Obstet Gynecol Reprod Biol. 2026;321:115050.
    PubMed         Abstract available
    
    
37. YALCIN I, Arslan O, Gokce A, Sozen H, et al
    Survival outcomes in sentinel node-positive vs. -negative endometrial cancer following adjustment for uterine risk factors: a propensity score-matched analysis (TRSGO-SLN-011).
    Eur J Obstet Gynecol Reprod Biol. 2026;321:115053.
    PubMed         Abstract available
    
    
38. POST BL, Verberkt C, Hup RJ, Jordans IPM, et al
    Niche presence and changes of the uterine scar in the first year after caesarean section: A prospective longitudinal study.
    Eur J Obstet Gynecol Reprod Biol. 2026;321:115051.
    PubMed         Abstract available
    
    

    
    Fertil Steril

39. 
    Corrigendum to "Prevention of moderate and severe ovarian hyperstimulation syndrome: a guideline" [Fertil Steril 2024;121:230-45].
    Fertil Steril. 2026 Mar 9:S0015-0282(26)00104.
    PubMed        
    
    
40. D'ANCONA G, Merlot B, Verrelli L, Boulos S, et al
    Robotic management of isolated endometriosis of sciatic nerve: a reproducible approach that can guide through the labyrinth of pelvic neuroanatomy.
    Fertil Steril. 2023;120.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

41. MOREL D, Parvu V, Andrews J, Stephenson P, et al
    HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assay.
    Gynecol Oncol. 2026;207:40-47.
    PubMed         Abstract available
    
    
42. LEE MW, Friedman EL, Erfani H, Keymeulen S, et al
    Assessment of survival and clinicopathologic characteristics associated with lymph node isolated tumor cells in epithelial ovarian cancer.
    Gynecol Oncol. 2026;207:50-56.
    PubMed         Abstract available
    
    
43. LEE MW, Vallejo A, Mandelbaum RS, Yessaian AA, et al
    Temporal trends of failure-to-rescue following perioperative complications in vulvar cancer surgery in the United States.
    Gynecol Oncol. 2023;177:1-8.
    PubMed         Abstract available
    
    
44. NASIOUDIS D, Latif NA, Ko EM, Cory L, et al
    Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma.
    Gynecol Oncol. 2023;177:14-19.
    PubMed         Abstract available
    
    
45. KIM JH, Park KN, Park EY, Jang MJ, et al
    Impact of warm saline irrigation, hyperthermic intraperitoneal chemotherapy on postoperative pain in primary ovarian cancer from the KOV-HIPEC-01 randomized trial.
    Gynecol Oncol. 2023;177:32-37.
    PubMed         Abstract available
    
    
46. MORTON M, McLaughlin EM, Calo CA, Lightfoot M, et al
    Prevalence of type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer: An opportunity for screening and intervention?
    Gynecol Oncol. 2023;177:46-52.
    PubMed         Abstract available
    
    
47. MARJON N, Guerra R, Freeman A, Mak J, et al
    Same day service: A genetic testing station model to improve germline genetic testing in patients with ovarian cancer.
    Gynecol Oncol. 2023;177:53-59.
    PubMed         Abstract available
    
    
48. AO W, Kim HI, Tommarello D, Conrads KA, et al
    Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment.
    Gynecol Oncol. 2023;177:60-71.
    PubMed         Abstract available
    
    
49. NARAYAN P, Ahsan MD, Webster EM, Perez L, et al
    Partner and localizer of BRCA2 (PALB2) pathogenic variants and ovarian cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2023;177:72-85.
    PubMed         Abstract available
    
    
50. NASIOUDIS D, Fernandez ML, Wong N, Powell DJ Jr, et al
    The spectrum of MAPK-ERK pathway genomic alterations in gynecologic malignancies: Opportunities for novel therapeutic approaches.
    Gynecol Oncol. 2023;177:86-94.
    PubMed         Abstract available
    
    
51. SAAB RH, Salvo G, Gonzales NR, Munsell MF, et al
    Social media use is associated with higher levels of anxiety and depression in patients with neuroendocrine carcinoma of the cervix: A NeCTuR study.
    Gynecol Oncol. 2023;177:95-102.
    PubMed         Abstract available
    
    
52. SPAGNOL G, Marchetti M, De Tommasi O, Vitagliano A, et al
    Simple rules, O-RADS, ADNEX and SRR model: Single oncologic center validation of diagnostic predictive models alone and combined (two-step strategy) to estimate the risk of malignancy in adnexal masses and ovarian tumors.
    Gynecol Oncol. 2023;177:109-116.
    PubMed         Abstract available
    
    
53. LIM H, Ju Y, Kim SI, Park JH, et al
    Clinical implications of histologic subtypes on survival outcomes in primary mucinous ovarian carcinoma.
    Gynecol Oncol. 2023;177:117-124.
    PubMed         Abstract available
    
    
54. TOBONI MD, Wu S, Farrell A, Xiu J, et al
    Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair gene mutation.
    Gynecol Oncol. 2023;177:132-141.
    PubMed         Abstract available
    
    
55. LEE HC, Jeong JW, Lee JH, Kim SH, et al
    High-dose (60 Gy) intensity-modulated radiotherapy with concurrent weekly cisplatin followed by intracavitary radiation in locally advanced cervical cancer: A phase II prospective clinical trial.
    Gynecol Oncol. 2023;177:142-149.
    PubMed         Abstract available
    
    
56. HUI C, Mendoza MG, von Eyben R, Dorigo O, et al
    Does lymph node assessment change the prognostic significance of substantial LVSI and p53 status in endometrial endometrioid carcinoma?
    Gynecol Oncol. 2023;177:150-156.
    PubMed         Abstract available
    
    
57. AGUSTI N, Viveros-Carreno D, Mora-Soto N, Ramirez PT, et al
    Diagnostic accuracy of sentinel lymph node frozen section analysis in patients with early-stage cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2023;177:157-164.
    PubMed         Abstract available
    
    
58. MARSH LA, Kim TH, Zhang M, Kubalanza K, et al
    Pathologic response to neoadjuvant chemotherapy in ovarian cancer and its association with outcome: A surrogate marker of survival.
    Gynecol Oncol. 2023;177:173-179.
    PubMed         Abstract available
    
    
59. HALL TR, MacDonald JE, Bylinowski KM, Alvarez EA, et al
    Management of chemotherapy hypersensitivity reactions and desensitization: An SGO clinical practice statement.
    Gynecol Oncol. 2023;177:180-185.
    PubMed         Abstract available
    
    

    
    Hum Pathol

60. ZHANG Z, Quddus MR, Sung CJ, Singh K, et al
    Morphologic and immunohistochemical study of HPV-related cervical adenosquamous carcinoma: Reappraisal of a poorly defined entity.
    Hum Pathol. 2026;170:106052.
    PubMed         Abstract available
    
    
61. SMITHGALL MC, Liu-Jarin X, Chen X, Singh K, et al
    Diagnostic utility of PRAME immunohistochemistry in PEComa family of tumors and morphologic mimics with emphasis on the gynecologic tract.
    Hum Pathol. 2023;138:12-17.
    PubMed         Abstract available
    
    
62. WANG X, Wang W, Chen J, Yang J, et al
    Expression Characteristics of Clinically Relevant Antibody-Drug Conjugate Targets in Gestational Trophoblastic Neoplasia.
    Hum Pathol. 2026 Mar 9:106102. doi: 10.1016/j.humpath.2026.106102.
    PubMed         Abstract available
    
    

    
    Hum Reprod

63. SAMARASINGHE SNS, Abbara A, Ortega PM, Ahmed AR, et al
    Ovulatory Recovery following weight loss in women with polycystic ovary syndrome and obesity: a post hoc analysis of the BAMBINI randomised controlled trial.
    Hum Reprod. 2026 Mar 11:deag037. doi: 10.1093.
    PubMed         Abstract available
    
    
64. LEWIN J, Vashisht A, Langan D, Vincent K, et al
    Endometriosis lesion distribution by age at presentation: an international multicentre database study.
    Hum Reprod. 2026 Mar 12:deag033. doi: 10.1093.
    PubMed         Abstract available
    
    
65. SAGE A, Rives N, Levade R, Real-Lhommet A, et al
    Fertility preservation and counselling in prepubertal and pubertal girls with Turner syndrome.
    Hum Reprod. 2026;41:453-467.
    PubMed         Abstract available
    
    

    
    Int J Cancer

66. LEHTINEN M, Lipsitch M, Pimenoff VN, Sundstrom K, et al
    Predicting optimal impact interventions in the post-HPV vaccination world.
    Int J Cancer. 2026 Jan 19. doi: 10.1002/ijc.70297.
    PubMed         Abstract available
    
    
67. MONAHAN KJ, Fleming P, Ryan NAJ, Monje-Garcia L, et al
    Outcomes from the English National Lynch Syndrome transformation project.
    Int J Cancer. 2026;158:2369-2379.
    PubMed         Abstract available
    
    
68. TSEGAYE AT, Mashele SA, Shing JZ, Mwansa-Kambafwile J, et al
    Race-specific temporal trends of HPV-related cancers in South Africa: An analysis of the South African National Cancer Registry, 2011-2022.
    Int J Cancer. 2025 Dec 31. doi: 10.1002/ijc.70323.
    PubMed         Abstract available
    
    
69. LEI J, Falcaro M, Brentnall AR, O'Mahony JF, et al
    Indicators to identify cancer screening providers with suboptimal case detection: A scoping review.
    Int J Cancer. 2026;158:2339-2358.
    PubMed         Abstract available
    
    
70. KARRBERG C, Gray P, Elfgren K, Milerad H, et al
    Nationwide audit of cervical cancer screening reveals unsatisfactory triage strategies and trends over time in incidence among cytology negative women.
    Int J Cancer. 2026 Mar 9. doi: 10.1002/ijc.70415.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

71. LIN L, Zhou L, Zhang X, Xiao Y, et al
    Efficacy of inositol supplementation for the prevention and treatment of gestational diabetes in pregnant women: Results from an umbrella meta-analysis.
    Int J Gynaecol Obstet. 2026 Mar 6. doi: 10.1002/ijgo.70854.
    PubMed         Abstract available
    
    
72. ADOMI M, Sakai T, Ishikawa T, Obara T, et al
    Medication use during pregnancy in Japan from 2005 to 2019: Trends and safety considerations.
    Int J Gynaecol Obstet. 2026 Mar 7. doi: 10.1002/ijgo.70860.
    PubMed         Abstract available
    
    
73. PATHIRATHNA ML, Haruna M, Nandasena HMRKG, Piumali AMM, et al
    Beyond the mirror: Exploring the impact of maternal body image attitudes on gestational weight gain and maternal and neonatal outcomes, a systematic review.
    Int J Gynaecol Obstet. 2026 Mar 10. doi: 10.1002/ijgo.70891.
    PubMed         Abstract available
    
    
74. CORREA TCF, Oliveira MAP
    Inverse association between obesity and intestinal endometriosis: Findings from a cross-sectional study.
    Int J Gynaecol Obstet. 2026 Mar 10. doi: 10.1002/ijgo.70930.
    PubMed         Abstract available
    
    
75. ROSH B, Hadad J, Gronich N
    Timing of conception after methotrexate and subsequent pregnancy outcomes: A retrospective cohort study.
    Int J Gynaecol Obstet. 2026 Mar 11. doi: 10.1002/ijgo.70938.
    PubMed         Abstract available
    
    
76. KONDAGULI NA, A P
    Study of association between serum anti-Mullerian hormone, glucose intolerance, and metabolic syndrome in women with polycystic ovarian syndrome: A comparative study.
    Int J Gynaecol Obstet. 2026 Mar 11. doi: 10.1002/ijgo.70866.
    PubMed         Abstract available
    
    
77. XIAOPANG R, Jie S, Wanjiao H, Man L, et al
    Expression and significance of ependymin-related protein 1 and neuregulin 4 in the serum of patients with polycystic ovary syndrome.
    Int J Gynaecol Obstet. 2026 Mar 12. doi: 10.1002/ijgo.70928.
    PubMed         Abstract available
    
    
78. QIN Z, Zheng A
    Bladder diverticulum mimicking an ovarian cyst: A diagnostic pitfall in gynecologic surgery.
    Int J Gynaecol Obstet. 2026 Mar 12. doi: 10.1002/ijgo.70896.
    PubMed        
    
    
79. MOHAMMED AA, Hassan HA, Hassan SS
    Asymptomatic uterine torsion at term due to multiple uterine fibroids with incidental posterior wall delivery and cesarean myomectomy: Case report.
    Int J Gynaecol Obstet. 2026 Mar 12. doi: 10.1002/ijgo.70957.
    PubMed        
    
    
80. ZULFIKAROGLU E
    Cervical cancer screening strategies in women 65 years and older in the human papillomavirus era: A systematic review and meta-analysis of human papillomavirus-based testing and self-sampling approaches.
    Int J Gynaecol Obstet. 2026 Mar 12. doi: 10.1002/ijgo.70962.
    PubMed         Abstract available
    
    
81. XIONG C, Wang Y, Dun C, Borahay MA, et al
    Assessing the impact of racial and ethnic disparities on 30-day emergency department visits after hysterectomy: A state-based retrospective cohort study.
    Int J Gynaecol Obstet. 2026 Mar 13. doi: 10.1002/ijgo.70950.
    PubMed         Abstract available
    
    
82. GERCIK ARZIK I, Golbasi H, Bayraktar B, Ankara Aktas H, et al
    Fetal pancreas and its vascular supply as early sonographic markers associated with gestational diabetes in the second trimester.
    Int J Gynaecol Obstet. 2026 Mar 13. doi: 10.1002/ijgo.70960.
    PubMed         Abstract available
    
    

    
    Int J Oncol

83. KIM A, Kim J, Kwak W, Mo K, et al
    Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer.
    Int J Oncol. 2026;68:57.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

84. WANG A, Bleil ME, Rosen MP, Redberg R, et al
    Ovarian Reserve and Endothelial Health in Healthy Reproductive Age Women.
    J Clin Endocrinol Metab. 2026 Mar 12:dgag105. doi: 10.1210.
    PubMed         Abstract available
    
    
85. ALESI S, Mason T, Ellery SJ, Rassie K, et al
    Early pregnancy biomarkers of inflammation and metabolic regulation in polycystic ovary syndrome.
    J Clin Endocrinol Metab. 2026 Mar 9:dgag098. doi: 10.1210.
    PubMed         Abstract available
    
    
86. ULDALL-TORP NM, Pedersen IB, Carle A, Karmisholt JS, et al
    Antithyroid drug treatment in pregnancy: A first report from the Danish PRETHYR multicenter study.
    J Clin Endocrinol Metab. 2026 Mar 6:dgag099. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    JAMA

87. ANDERER S
    Pregnancy Biomarkers May Offer Insight Into Future CVD Risk.
    JAMA. 2026 Mar 13. doi: 10.1001/jama.2026.1012.
    PubMed        
    
    

    
    Lancet

88. CARLIN N
    Cancer in pregnancy: navigating two medical systems.
    Lancet. 2026 Mar 6:S0140-6736(26)00465-4. doi: 10.1016/S0140-6736(26)00465.
    PubMed        
    
    

    
    Obstet Gynecol

89. EINSTEIN MH, Zhou N, Gabor L, Sahasrabuddhe VV, et al
    Primary Human Papillomavirus Testing and Other New Technologies for Cervical Cancer Screening.
    Obstet Gynecol. 2023 Sep 14. doi: 10.1097/AOG.0000000000005393.
    PubMed         Abstract available
    
    
90. HAN MN, Munro MG
    Endometrial Polyps.
    Obstet Gynecol. 2026 Mar 12. doi: 10.1097/AOG.0000000000006232.
    PubMed         Abstract available
    
    

    
    Oncogene

91. EL BABA R, Haidar Ahmad S, Monnien F, Mansar R, et al
    Polyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells.
    Oncogene. 2023;42:3047-3061.
    PubMed         Abstract available
    
    

    
    PLoS Med

92. TOSUN A
    From pain to policy: Improving endometriosis awareness, diagnosis, and treatment.
    PLoS Med. 2026;23:e1004981.
    PubMed         Abstract available
    
    

    
    PLoS One

93. MITCHELL LE, Phillips E, Jennett CJ, Bavor C, et al
    Experiences of HPV self-collection among Aboriginal and Torres Strait Islander women and people with a cervix.
    PLoS One. 2026;21:e0326551.
    PubMed         Abstract available
    
    
94. JONSDOTTIR G, Lantz E, Beermann M, Paschou M, et al
    Symptom improvement in adenomyosis patients after ultrasound guided microwave ablation or uterine artery embolization, A randomized controlled pilot study.
    PLoS One. 2026;21:e0343949.
    PubMed         Abstract available
    
    
95. HE H, Ning P, Chen X, Lin J, et al
    Knockdown of miR-21-5P targets and regulates PDCD4-induced apoptosis in ovarian granulosa cells and ameliorates in sulin resistance in polycystic ovary syndrom.
    PLoS One. 2026;21:e0343735.
    PubMed         Abstract available
    
    
96. LIU P, Zhang Y, Chen X, Tang L, et al
    Exploring the effects of IFN-tau on LPS-induced endometritis in cows based on transcriptomics.
    PLoS One. 2026;21:e0343553.
    PubMed         Abstract available
    
    
97. HASBAY E, Sahin S, Kelten Talu EC, Sanci M, et al
    MRI differentiation of usual type endocervical adenocarcinoma and cervical squamous cell carcinoma.
    PLoS One. 2026;21:e0343764.
    PubMed         Abstract available
    
    

    
    Radiology

98. NOUGARET S, Lakhman Y, Suarez-Weiss KE, Patel-Lippman K, et al
    Imaging in Advanced Epithelial Ovarian Cancer: Assessment of Peritoneal Spread.
    Radiology. 2026;318:e250116.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum